13F

Stock

Neurocrine Biosciences Inc

NBIX · held by 4 managers

Reported value

$22.8M

Holders

4

+0 new · −1 exited

Holders’ est. mark

−$7.18M

Price effect on 3 books still in the name

Largest holder

$18.5M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC340.5K$18.5M−$6.88MCut−$6.69M
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main40.3K$3.8M−$278.9KCut−$1.25M
Swiss Life Asset Management Ltd4.53K$427K−$18.2KAdded$160.5K

Who left

Positions as of Q2 2023. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.